SCHEMBL8375772

SCHEMBL8375772

CCCCCc1c(O)noc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GCGR P47871 2/20 0.45
HSD11B1 P28845 1/20 0.42
S1PR1 P21453 2/20 0.40
GPR84 Q9NQS5 1/20 0.40
S1PR3 Q99500 1/20 0.40
PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11994167 0.80 BRD4 (0.43) GCGRHSD11B1S1PR1S1PR3
SCHEMBL2568160 0.77 PTPN1 (0.55) HSD11B1S1PR1S1PR3
SCHEMBL7375744 0.76 NOTUM (0.42) S1PR1
SCHEMBL8125246 0.75 NOS1 (0.43) S1PR1S1PR3
SCHEMBL8125242 0.75 NOS1 (0.43) S1PR1S1PR3
SCHEMBL8380048 0.75 S1PR1 (0.42) S1PR1S1PR3
Hydrochloric Acid SCHEMBL8376577 0.73 FAAH (0.43) HSD11B1S1PR1
SCHEMBL6581665 0.73 PTPN1 (0.44)
SCHEMBL8376467 0.73 ALDH1A1 (0.37) S1PR1
Hydrochloric Acid SCHEMBL8379833 0.72 FAAH (0.45) S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed